C.R. Bard Inc. (BCR): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

C.R. Bard ( BCR) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.7%. By the end of trading, C.R. Bard rose $1.56 (1.4%) to $115.71 on average volume. Throughout the day, 506,717 shares of C.R. Bard exchanged hands as compared to its average daily volume of 536,400 shares. The stock ranged in a price between $113.88-$115.89 after having opened the day at $114.40 as compared to the previous trading day's close of $114.15. Other companies within the Health Services industry that increased today were: Pingtan Marine Enterprise ( PME), up 15.0%, Unilife Corporation ( UNIS), up 10.2%, InspireMD ( NSPR), up 8.4% and Misonix ( MSON), up 7.3%.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $9.1 billion and is part of the health care sector. Shares are up 15.8% year to date as of the close of trading on Wednesday. Currently there are 5 analysts that rate C.R. Bard a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates C.R. Bard as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share.

On the negative front, Electromed ( ELMD), down 5.8%, Sunshine Heart ( SSH), down 4.6%, Spherix ( SPEX), down 4.5% and Retractable Technologies ( RVP), down 4.5%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead

Deals of the Week: Waiting for Clarity

Merger Buzz Drives Akorn to Top of Health Chart in April

Deals of the Week: Reason for Optimism

Good Medicine Makes for 3 Good Charts